1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow ABBV-3373: new trials by email Literature Review of ABBV-3373 trials Research Report on ABBV-3373
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA) ABBV-3373, Placebo for ABBV-3373, Adalimumab - Rheumatoid Arthritis (RA) | Phase 2 | Completed | AbbVie | 48 | 2019-03-27 | 2021-07-19 |
AbbVie (1)
Germany (1) · Hungary (1) · Israel (1) · Netherlands (1) · Poland (1) · Puerto Rico (1) · United States (1)
2018 (1)